pluripotent stem cells

Weekly reads: court case, cancer stem cells, skin, pluripotency, & more

chen et al fig 1e nat comm 2021 phc1

This was a busy week for me working on a grant due Friday and a bunch of other stuff including happily analyzing a bunch of data, but there were tons of interesting papers recently including on pluripotency. California stem cell clinic court case on in the background Along the way this week I was occasionally …

Weekly reads: court case, cancer stem cells, skin, pluripotency, & more Read More »

Recommended reads: pluripotent stem cells, neural crest, cancer, more

pluripotent stem cell, neural crest cells

There has been quite a lot of pubs on research on pluripotent stem cells published lately. These include some more surprising findings such as a potential role for pluripotency-related programming in neural crest development. Here the week’s recommended reads. Neural Crest research: ties to factors involved in pluripotent stem cells Science, Reactivation of the pluripotency …

Recommended reads: pluripotent stem cells, neural crest, cancer, more Read More »

OCT4-SOX DNA dance, PRC2, a noisy competition & more cell weekly reads

EMBO-J-2020-Fig-3b-Salazar-Roa-et-al

What’s new in the stem cell, cell therapy, and regenerative medicine world as well as biomedical science more generally including cancer? There’s quite a bit of news as reflected in media pieces and new pubs. Today’s post is focused on pubs that just came out. For last week’s recommended reads see here. Oct4-Sox2 Nucleosome Binding …

OCT4-SOX DNA dance, PRC2, a noisy competition & more cell weekly reads Read More »

Lorenz Studer on Day 1 #ISSCR2018: HESC-based therapies for Parkinson’s Disease

GForce_Superhero_logo

One of the highlights of Day 1 of #ISSCR2018 for me so far was the talk by Lorenz Studer (Co-Founder of BlueRock) on the use of human embryonic stem cell (HESC)-derived dopamine neurons for Parkinson’s Disease. Note that for this post and if I have time any others on this meeting, they are probably going …

Lorenz Studer on Day 1 #ISSCR2018: HESC-based therapies for Parkinson’s Disease Read More »

Perspectives on pig human chimera paper

human-pig-chimera

A new paper focused on human and other chimeras just came out today in Cell reporting a number of findings, but most strikingly successful generation of human-pig chimeras in utero. The paper, entitled, “Interspecies Chimerism with Mammalian Pluripotent Stem Cells” describes various chimeras including mouse-rat ones, although those have previously been reported. This work comes …

Perspectives on pig human chimera paper Read More »

Silva Comments on MBD3/NuRD Debate with Jacob Hanna

Jose-Silva

What’s the deal with the tension between José Silva and Jacob Hanna over pluripotency? Researchers probing how to reprogram cells into powerful stem cells (induced pluripotent stem cells or IPSCs) and what the molecular mechanisms are behind this process have become entangled in a conflict. Of course over the years scientists including stem cell scientists have …

Silva Comments on MBD3/NuRD Debate with Jacob Hanna Read More »

If I only had a brain: brain organoids from pluripotent stem cells

In a first for the field, scientists have used human pluripotent stem cells to grow miniature brain-like structures (brain organoids) in a dish in a lab (see beautiful image of one of these “mini-brains” at left from the paper). This exciting, pioneering feat, accomplished by a team from the Austrian Academy of Science in Vienna …

If I only had a brain: brain organoids from pluripotent stem cells Read More »

Mike West Interview Part 3: key flaw in stem cell field

Michael-West-PhD-CEO-of-BioTime-1-934x10241

I’m doing a series of posts on my recent conversation with BioTime CEO and pioneer of the stem cell field, Dr. Mike West. You can read Part 1 and Part 2 on Geron, ACT, and the history of the pluripotent stem cell field, particularly embryonic stem cells (ESCs). Today in Part 3, I am focusing on …

Mike West Interview Part 3: key flaw in stem cell field Read More »

BioTime CEO Mike West Interview Part 2: Geron & hESC

Michael-West-PhD-CEO-of-BioTime-1-934x10241

When you want to both know the real history of the pluripotent stem cell-based biotech industry and perspectives on its future, there are only a handful of people to turn to and one of them is definitely Dr. Michael West, CEO of BioTime. I’m doing a several part series of blog posts on a lengthy …

BioTime CEO Mike West Interview Part 2: Geron & hESC Read More »

Jury is still out on purported adult pluripotent stem cells despite new MUSE paper

MUSE-cells

Are MUSE cells for real? Stem cells come in different types that vary in a key property called “potency”, but very few are pluripotent. The more potency, the greater the flexibility of a stem cell to make other cell types. Flexibility in the cellular world is power. The most powerful stem cells generally used are …

Jury is still out on purported adult pluripotent stem cells despite new MUSE paper Read More »